Stress has been linked to all the leading causes of death, including cardiovascular disease, cancer, accidents, and suicide.
Almost 90 percent of all visits to primary healthcare providers are due to stress-related problems.
It is estimated that 1 million Americans miss work due to stress-related complaints.
Transcendenal Mediitation (TM) has been shown to prevent and treat stress related disorders.
The physiological effects of stress
How Transcendental Meditation (TM) affects the brain
How Transcendental Meditation (TM) affects patients with anxiety, hypertension, heart disease, substance abuse, PTSD, and other stress-related disorders.
This program has been designed for a multidisciplinary physician, PA, NP and nurse audience.
No commercial support has been received for this program.
Release Date: February 08, 2016 -- Expiration Date: February 08, 2018
Faculty: Stuart Rothenberg, MD
By the end of the session the participant will be able to:
ACCREDITATION FOR THIS COURSE HAS EXPIRED. YOU MAY VIEW THE PROGRAM, BUT CME / CE IS NO LONGER AVAILABLE AND NO CERTIFICATE WILL BE ISSUED.
As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved through content review ScientiaCME.
Dr. Stuart Rothenberg, MD discloses that he is medical director of the TM Health Professionals Association.
Disclosures of Educational Planner: Charles Turck, PharmD is an officer and part owner of ScientiaCME, LLC.
Commercial Support Disclosure: No Commercial Support
*Required to view Printable PDF Version
Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.
Best Practices and Advances in Treatment Strategies in Bipolar Disorder Pharmacotherapy
Alcohol Use Disorder (AUD): Therapeutic Updates and Best Practices
Major Depressive Disorder (MDD): Updates from the American Psychiatric Association Annual Meeting (APA) 2017
Schizophrenia: Updates from the American Psychiatric Association Annual Meeting (APA) 2017